Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Int J Mol Epidemiol Genet. 2018;9(5):43-54

Authors: Jiménez-Ávila CE, Villegas-Ruíz V, Zapata-Tarres M, Rubio-Portillo AE, Pérez López EI, Zenteno JC, Juárez-Méndez S

Abstract
The alternative splicing plays an important role to generate protein diversity. Recent studies have shown alterations in alternative splicing, resulting in loss, gain or changes of functions in the resulting protein. Specific products of alternative splicing are known to contribute in cancer-related mechanisms, such as angiogenesis, migration, adhesion and cell proliferation, among others. We using high-density microarrays reported a CENP-E as a one of significant transcript expressed and potentially is alternatively spliced in cancer. We focus in validate alternative splicing of CENP-E transcript using RT-PCR and sequencing in different cancer cell lines. We performed RT-PCR using specific primers designed to delimit the non-reported alternative splicing in CENP-E transcript. Our results showed the co-expression of the variant one and two of CENP-E in all cell lines evaluated. We detected more expression of variant one than two. Moreover, we identify an alternative 5'splice site of CENP-E in the exon 38 and was observed in RoVa cell line. Additionally, we characterized alternative skipping from exon 20 (NAT-CENP-E), these alternative splicing was observed in all cell lines evaluated except RoVa. Finally, we corroborate alternative mRNA splicing in leukemia patients using quantitative RT-PCR, in 71.8% of the patients NAT-CENP-E is downregulated and 28.2% is overexpressed.

PMID: 30515258 [PubMed]

from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2EiyQAV